CAR-T Cell Therapy: Firing Up the Engines as a Possible B-Cell Directed Treatment for MS
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of some cancers, especially leukemias and lymphomas. But does it offer similar promise in multiple sclerosis (MS)? CMSC annual meeting speaker Jeffrey Cohen, MD, Director of …